FDA Drug Application (202286) for TRANEXAMIC ACID by APOTEX INC

Back to FDA Applications sponsored by APOTEX INC

Application Number202286
Product Number001
FormTABLET;ORAL
Dosage650MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameTRANEXAMIC ACID
Active IngredientTRANEXAMIC ACID

Active IngredientCount
List of drugs with Active Ingredient TRANEXAMIC ACID3


Back to FDA Applications sponsored by APOTEX INC